Mentice AB (publ) (MNTC.ST)
SEK 19.0
(0.53%)
SEK 19.0
(0.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -49.56 Million SEK | -61.92% |
| 2022 | -30.61 Million SEK | -1625.16% |
| 2021 | 2 Million SEK | 105.39% |
| 2020 | -37.24 Million SEK | -14.27% |
| 2019 | -32.59 Million SEK | -82.89% |
| 2018 | -17.82 Million SEK | -21.13% |
| 2017 | -14.71 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -49.56 Million SEK | 0.0% |
| 2024 Q2 | -51.08 Million SEK | -3.06% |
| 2023 Q1 | -31.02 Million SEK | -1.36% |
| 2023 Q3 | -63.26 Million SEK | -191.57% |
| 2023 FY | -49.56 Million SEK | -61.92% |
| 2023 Q4 | -49.56 Million SEK | 21.66% |
| 2023 Q2 | -21.69 Million SEK | 30.06% |
| 2022 Q2 | -16.88 Million SEK | -1575.4% |
| 2022 FY | -30.61 Million SEK | -1625.16% |
| 2022 Q1 | -1 Million SEK | -150.22% |
| 2022 Q4 | -30.61 Million SEK | -142.01% |
| 2022 Q3 | -12.64 Million SEK | 25.11% |
| 2021 Q1 | -17.83 Million SEK | 52.1% |
| 2021 Q4 | 2 Million SEK | -65.87% |
| 2021 FY | 2 Million SEK | 105.39% |
| 2021 Q3 | 5.88 Million SEK | 134.79% |
| 2021 Q2 | -16.89 Million SEK | 5.26% |
| 2020 Q1 | -28.84 Million SEK | 11.49% |
| 2020 FY | -37.24 Million SEK | -14.27% |
| 2020 Q4 | -37.24 Million SEK | -54.65% |
| 2020 Q3 | -24.08 Million SEK | 33.95% |
| 2020 Q2 | -36.45 Million SEK | -26.38% |
| 2019 Q3 | -46.38 Million SEK | 30.65% |
| 2019 Q2 | -66.89 Million SEK | -950.04% |
| 2019 Q1 | 7.86 Million SEK | 144.16% |
| 2019 FY | -32.59 Million SEK | -82.89% |
| 2019 Q4 | -32.59 Million SEK | 29.74% |
| 2018 Q1 | 14.71 Million SEK | 0.0% |
| 2018 FY | -17.82 Million SEK | -21.13% |
| 2018 Q4 | -17.82 Million SEK | 0.0% |
| 2017 FY | -14.71 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | -41.011% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 104.04% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 104.04% |
| Arcoma AB | -1.12 Million SEK | -4293.972% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 145.107% |
| BICO Group AB (publ) | 927.9 Million SEK | 105.342% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 138.481% |
| CellaVision AB (publ) | -56.94 Million SEK | 12.957% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | -233.159% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | -486.195% |
| C-Rad AB (publ) | -127.6 Million SEK | 61.157% |
| Duearity AB (publ) | 10.23 Million SEK | 584.449% |
| Dignitana AB (publ) | 13.07 Million SEK | 479.017% |
| Episurf Medical AB (publ) | -52.7 Million SEK | 5.951% |
| Getinge AB (publ) | 5.4 Billion SEK | 100.916% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | -41.397% |
| Iconovo AB (publ) | -10.75 Million SEK | -360.832% |
| Integrum AB (publ) | -10.47 Million SEK | -373.095% |
| Luxbright AB (publ) | -13.83 Million SEK | -258.291% |
| OssDsign AB (publ) | -162.78 Million SEK | 69.553% |
| Paxman AB (publ) | -11.41 Million SEK | -334.353% |
| Promimic AB (publ) | -50.32 Million SEK | 1.508% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 359.906% |
| SciBase Holding AB (publ) | -27.32 Million SEK | -81.394% |
| ScandiDos AB (publ) | -1.53 Million SEK | -3137.361% |
| Sectra AB (publ) | -772.85 Million SEK | 93.587% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 78.154% |
| Senzime AB (publ) | -139.54 Million SEK | 64.481% |
| SpectraCure AB (publ) | -50.23 Million SEK | 1.334% |
| Stille AB | -178.5 Million SEK | 72.234% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 104.036% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 76.909% |